KalVista Pharmaceuticals Up Over 17%, on Pace for Largest Percent Increase Since September 2024 -- Data Talk

Dow Jones

Jul 07, 2025

KalVista Pharmaceuticals, Inc. $(KALV)$ is currently at $14.06, up $2.08 or 17.36%

--Would be highest close since June 10, 2025, when it closed at $14.21

--On pace for largest percent increase since Sept. 27, 2024, when it rose 23.4%

--Currently up four consecutive days; up 24.37% over this period

--Longest winning streak since June 9, 2025, when it rose for six straight trading days

--Best four day stretch since the four days ending Sept. 27, 2024, when it rose 26.18%

--Up 24.37% month-to-date

--Up 66% year-to-date

--Down 88.89% from its all-time closing high of $126.56 on June 8, 2015

--Up 15.25% from 52 weeks ago (July 8, 2024), when it closed at $12.20

--Down 8.64% from its 52-week closing high of $15.39 on July 23, 2024

--Up 90% from its 52-week closing low of $7.40 on Jan. 14, 2025

--Traded as high as $14.60; highest intraday level since June 10, 2025, when it hit $14.87

--Up 21.87% at today's intraday high; largest intraday percent increase since Sept. 27, 2024, when it rose as much as 23.6%

All data as of 11:30:42 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 07, 2025 11:32 ET (15:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2549455669"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2549455669\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2549455669?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-07 23:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2549455669","market":"nz","top_or_hot":-1,"title":"KalVista Pharmaceuticals Up Over 17%, on Pace for Largest Percent Increase Since September 2024 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  KalVista Pharmaceuticals, Inc. <a href=\"https://laohu8.com/S/KALV\">$(KALV)$</a> is currently at $14.06, up $2.08 or 17.36% \n</p>\n<pre>\n \n</pre>\n<p>\n     --Would be highest close since June 10, 2025, when it closed at $14.21 \n</p>\n<p>\n     --On pace for largest percent increase since Sept. 27, 2024, when it rose 23.4% \n</p>\n<p>\n     --Currently up four consecutive days; up 24.37% over this period \n</p>\n<p>\n     --Longest winning streak since June 9, 2025, when it rose for six straight trading days \n</p>\n<p>\n     --Best four day stretch since the four days ending Sept. 27, 2024, when it rose 26.18% \n</p>\n<p>\n     --Up 24.37% month-to-date \n</p>\n<p>\n     --Up 66% year-to-date \n</p>\n<p>\n     --Down 88.89% from its all-time closing high of $126.56 on June 8, 2015 \n</p>\n<p>\n     --Up 15.25% from 52 weeks ago (July 8, 2024), when it closed at $12.20 \n</p>\n<p>\n     --Down 8.64% from its 52-week closing high of $15.39 on July 23, 2024 \n</p>\n<p>\n     --Up 90% from its 52-week closing low of $7.40 on Jan. 14, 2025 \n</p>\n<p>\n     --Traded as high as $14.60; highest intraday level since June 10, 2025, when it hit $14.87 \n</p>\n<p>\n     --Up 21.87% at today's intraday high; largest intraday percent increase since Sept. 27, 2024, when it rose as much as 23.6% \n</p>\n<pre>\n \n</pre>\n<p>\n     All data as of 11:30:42 AM ET \n</p>\n<pre>\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 07, 2025 11:32 ET (15:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KalVista Pharmaceuticals Up Over 17%, on Pace for Largest Percent Increase Since September 2024 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKalVista Pharmaceuticals Up Over 17%, on Pace for Largest Percent Increase Since September 2024 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-07 23:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  KalVista Pharmaceuticals, Inc. <a href=\"https://laohu8.com/S/KALV\">$(KALV)$</a> is currently at $14.06, up $2.08 or 17.36% \n</p>\n<pre>\n \n</pre>\n<p>\n     --Would be highest close since June 10, 2025, when it closed at $14.21 \n</p>\n<p>\n     --On pace for largest percent increase since Sept. 27, 2024, when it rose 23.4% \n</p>\n<p>\n     --Currently up four consecutive days; up 24.37% over this period \n</p>\n<p>\n     --Longest winning streak since June 9, 2025, when it rose for six straight trading days \n</p>\n<p>\n     --Best four day stretch since the four days ending Sept. 27, 2024, when it rose 26.18% \n</p>\n<p>\n     --Up 24.37% month-to-date \n</p>\n<p>\n     --Up 66% year-to-date \n</p>\n<p>\n     --Down 88.89% from its all-time closing high of $126.56 on June 8, 2015 \n</p>\n<p>\n     --Up 15.25% from 52 weeks ago (July 8, 2024), when it closed at $12.20 \n</p>\n<p>\n     --Down 8.64% from its 52-week closing high of $15.39 on July 23, 2024 \n</p>\n<p>\n     --Up 90% from its 52-week closing low of $7.40 on Jan. 14, 2025 \n</p>\n<p>\n     --Traded as high as $14.60; highest intraday level since June 10, 2025, when it hit $14.87 \n</p>\n<p>\n     --Up 21.87% at today's intraday high; largest intraday percent increase since Sept. 27, 2024, when it rose as much as 23.6% \n</p>\n<pre>\n \n</pre>\n<p>\n     All data as of 11:30:42 AM ET \n</p>\n<pre>\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 07, 2025 11:32 ET (15:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2549455669","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2549455669","pubTimestamp":1751902320,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"KalVista Pharmaceuticals, Inc.  is currently at $14.06, up $2.08 or 17.36%. --Would be highest close since June 10, 2025, when it closed at $14.21. --On pace for largest percent increase since Sept. 27, 2024, when it rose 23.4%. --Currently up four consecutive days; up 24.37% over this period. --Longest winning streak since June 9, 2025, when it rose for six straight trading days. --Down 88.89% from its all-time closing high of $126.56 on June 8, 2015. --Up 15.25% from 52 weeks ago , when it closed at $12.20. --Down 8.64% from its 52-week closing high of $15.39 on July 23, 2024. --Traded as high as $14.60; highest intraday level since June 10, 2025, when it hit $14.87. --Up 21.87% at today's intraday high; largest intraday percent increase since Sept. 27, 2024, when it rose as much as 23.6%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","KALV":"Kalvista Pharmaceuticals Inc"},"translate_title":"KalVista Pharmaceuticals上涨超过17%，有望创2024年9月以来最大百分比涨幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KALV":0.9},"content_text":"KalVista Pharmaceuticals, Inc. $(KALV)$ is currently at $14.06, up $2.08 or 17.36% \n\n\n \n\n\n     --Would be highest close since June 10, 2025, when it closed at $14.21 \n\n\n     --On pace for largest percent increase since Sept. 27, 2024, when it rose 23.4% \n\n\n     --Currently up four consecutive days; up 24.37% over this period \n\n\n     --Longest winning streak since June 9, 2025, when it rose for six straight trading days \n\n\n     --Best four day stretch since the four days ending Sept. 27, 2024, when it rose 26.18% \n\n\n     --Up 24.37% month-to-date \n\n\n     --Up 66% year-to-date \n\n\n     --Down 88.89% from its all-time closing high of $126.56 on June 8, 2015 \n\n\n     --Up 15.25% from 52 weeks ago (July 8, 2024), when it closed at $12.20 \n\n\n     --Down 8.64% from its 52-week closing high of $15.39 on July 23, 2024 \n\n\n     --Up 90% from its 52-week closing low of $7.40 on Jan. 14, 2025 \n\n\n     --Traded as high as $14.60; highest intraday level since June 10, 2025, when it hit $14.87 \n\n\n     --Up 21.87% at today's intraday high; largest intraday percent increase since Sept. 27, 2024, when it rose as much as 23.6% \n\n\n \n\n\n     All data as of 11:30:42 AM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 07, 2025 11:32 ET (15:32 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}